Is Sanofi (SNY) The Best Immunology Stock To Buy Now?
We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...
Sanofi (SNY): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other pharmaceutical stocks.
MarketBeat on MSN2d
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
(NASDAQ: REGN) stock has gone relatively unnoticed from major headlines in 2024 as GLP-1 makers like Novo Nordisk A/S (NYSE: ...
Nasdaq11d
Sanofi Signs Share Purchase Deal To Sell 50% Controlling Stake In Opella To CD&R
Sanofi now said the agreement follows completion ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
Sanofi to sell 50% stake in consumer health unit to CD&R
Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
Nasdaq12d
Regeneron and Sanofi Announce FDA Priority Review for Dupixent® as Potential First Targeted Treatment for Bullous Pemphigoid
Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent ...
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) and Sanofi SA (NASDAQ:SNY) presented new, detailed results from the RELIEVE ...